Metabolically healthy obesity and development of chronic kidney disease: A cohort study

Annals of Internal Medicine

Volumn 164, Issue 5, 2016, Pages 305-312

  Chang, Yoosoo ^a,b   Ryu, Seungho ^a,b   Choi, Yuni ^a   Zhang, Yiyi ^c   Cho, Juhee ^b   Kwon, Min Jung ^a   Hyun, Young Youl ^d   Lee, Kyu Beck ^d   Kim, Hyang ^d   Jung, Hyun Suk ^a   Yun, Kyung Eun ^g   Ahn, Jiin ^a   Rampal, Sanjay ^e   Zhao, Di ^c   Suh, Byung Seong ^d   Chung, Eun Cheol ^d   Shin, Hocheol ^d   Pastor Barriuso, Roberto ^f   Guallar, Eliseo ^c  

^a School of Medicine   (South Korea)

^b Sungkyunkwan University   (South Korea)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d Sungkyunkwan University School of Medicine   (South Korea)

^e UNIVERSITY OF MALAYA   (Malaysia)

^f CARLOS III INSTITUTE OF HEALTH   (Spain)

^g NONE

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIVER ENZYME; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; OBESITY; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING; SOUTH KOREA; SYSTOLIC BLOOD PRESSURE; UNDERWEIGHT; COMPLICATION; INCIDENCE; METABOLICALLY BENIGN OBESITY; PROSPECTIVE STUDY; RENAL INSUFFICIENCY, CHRONIC; RISK FACTOR;

ADULT; BODY MASS INDEX; FEMALE; HUMANS; INCIDENCE; MALE; OBESITY, METABOLICALLY BENIGN; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; REPUBLIC OF KOREA; RISK FACTORS;

EID: 84959287858     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M15-1323     Document Type: Article

References (33)

1. Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382:260-72. [PMID: 23727169] doi:10.1016/S0140-6736(13) 60687-X
2. Eckardt KU, Coresh J, Devuyst O, Johnson RJ, Köttgen A, Levey AS, et al. Evolving importance of kidney disease: from subspecialty to global health burden. Lancet. 2013;382:158-69. [PMID: 23727165] doi:10.1016/S0140-6736(13)60439-0
3. McLellan F. Obesity rising to alarming levels around the world. Lancet. 2002;359:1412. [PMID: 11978348]
4. Foster MC, Hwang SJ, Larson MG, Lichtman JH, Parikh NI, Vasan RS, et al. Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study. Am J Kidney Dis. 2008;52:39-48. [PMID: 18440684] doi:10.1053/j.ajkd.2008.03.003
5. Primeau V, Coderre L, Karelis AD, Brochu M, Lavoie ME, Messier V, et al. Characterizing the profile of obese patients who are metabolically healthy. Int J Obes (Lond). 2011;35:971-81. [PMID: 20975726] doi:10.1038/ijo.2010.216
6. Stefan N, Kantartzis K, Machann J, Schick F, Thamer C, Rittig K, et al. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med. 2008;168:1609-16. [PMID: 18695074] doi:10.1001/archinte.168.15.1609
7. Hashimoto Y, Tanaka M, Okada H, Senmaru T, Hamaguchi M, Asano M, et al. Metabolically healthy obesity and risk of incident CKD. Clin J Am Soc Nephrol. 2015;10:578-83. [PMID: 25635035] doi:10.2215/CJN.08980914
8. Zhang Y, Chang Y, Ryu S, Cho J, Lee WY, Rhee EJ, et al. Thyroid hormone levels and incident chronic kidney disease in euthyroid individuals: the Kangbuk Samsung Health Study. Int J Epidemiol. 2014;43:1624-32. [PMID: 25011453]
9. Kuk JL, Ardern CI. Are metabolically normal but obese individuals at lower risk for all-cause mortality? Diabetes Care. 2009;32:2297-9. [PMID: 19729521] doi:10.2337/dc09-0574
10. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al; International Diabetes Federation Task Force on Epidemiology and Prevention. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640-5. [PMID: 19805654] doi:10.1161/CIRCULATIONAHA.109.192644
11. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-9. [PMID: 3899825]
12. Chang Y, Kim BK, Yun KE, Cho J, Zhang Y, Rampal S, et al. Metabolically-healthy obesity and coronary artery calcification. J Am Coll Cardiol. 2014;63:2679-86. [PMID: 24794119] doi:10.1016/j.jacc .2014.03.042
13. Malavolti M, Mussi C, Poli M, Fantuzzi AL, Salvioli G, Battistini N, et al. Cross-calibration of eight-polar bioelectrical impedance analysis versus dual-energy X-ray absorptiometry for the assessment of total and appendicular body composition in healthy subjects aged 21-82 years. Ann Hum Biol. 2003;30:380-91. [PMID: 12881138]
14. World Health Organization. The Asia-Pacific perspective: redefining obesity and its treatment. Sydney, Australia: Health Communications Australia Pty Limited; 2000. Accessed at www.wpro.who.int/nutrition/documents/docs/Redefiningobesity.pdf on 7 January 2016.
15. Chang Y, Jung HS, Yun KE, Cho J, Cho YK, Ryu S. Cohort study of non-alcoholic fatty liver disease, NAFLD fibrosis score, and the risk of incident diabetes in a Korean population. Am J Gastroenterol. 2013;108:1861-8. [PMID: 24100261] doi:10.1038/ajg.2013.349
16. Mathiesen UL, Franzén LE, Aselius H, Resjö M, Jacobsson L, Foberg U, et al. Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases. Dig Liver Dis. 2002;34:516-22. [PMID: 12236486]
17. Manjunath G, Sarnak MJ, Levey AS. Prediction equations to estimate glomerular filtration rate: an update. Curr Opin Nephrol Hypertens. 2001;10:785-92. [PMID: 11706306]
18. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604-12. [PMID: 19414839]
19. Robins JM, Hernán MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology. 2000;11:550-60. [PMID: 10955408]
20. Cole SR, Hernán MA. Adjusted survival curves with inverse probability weights. Comput Methods Programs Biomed. 2004;75:45-9. [PMID: 15158046]
21. Royston P, Parmar MK. Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects. Stat Med. 2002;21:2175-97. [PMID: 12210632]
22. Kramer CK, Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign conditions? A systematic review and meta-analysis. Ann Intern Med. 2013;159:758-69. [PMID: 24297192] doi:10.7326/0003-4819-159-11-201312030-00008
23. de Jong PE, Verhave JC, Pinto-Sietsma SJ, Hillege HL; PREVEND study group. Obesity and target organ damage: the kidney. Int J Obes Relat Metab Disord. 2002;26 Suppl 4:S21-4. [PMID: 12457295]
24. Wickman C, Kramer H. Obesity and kidney disease: potential mechanisms. Semin Nephrol. 2013;33:14-22. [PMID: 23374890] doi: 10.1016/j.semnephrol.2012.12.006
25. Garland JS. Elevated body mass index as a risk factor for chronic kidney disease: current perspectives. Diabetes Metab Syndr Obes. 2014;7:347-55. [PMID: 25114577] doi:10.2147/DMSO.S46674
26. Kalaitzidis RG, Siamopoulos KC. The role of obesity in kidney disease: recent findings and potential mechanisms. Int Urol Nephrol. 2011;43:771-84. [PMID: 21544651] doi:10.1007/s11255-011-9974-1
27. Thethi T, Kamiyama M, Kobori H. The link between the reninangiotensin-aldosterone system and renal injury in obesity and the metabolic syndrome. Curr Hypertens Rep. 2012;14:160-9. [PMID: 22302531] doi:10.1007/s11906-012-0245-z
28. Hunley TE, Ma LJ, Kon V. Scope and mechanisms of obesityrelated renal disease. Curr Opin Nephrol Hypertens. 2010;19:227-34. [PMID: 20134323] doi:10.1097/MNH.0b013e3283374c09
29. Stefan N, Artunc F, Heyne N, Machann J, Schleicher ED, Häring HU. Obesity and renal disease: not all fat is created equal and not all obesity is harmful to the kidneys. Nephrol Dial Transplant. 2014. [PMID: 24753460]
30. de Vries AP, Ruggenenti P, Ruan XZ, Praga M, Cruzado JM, Bajema IM, et al; ERA-EDTA Working Group Diabesity. Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease. Lancet Diabetes Endocrinol. 2014;2:417-26. [PMID: 24795255] doi:10 .1016/S2213-8587(14)70065-8
31. Abdullah A, Wolfe R, Stoelwinder JU, de Courten M, Stevenson C, Walls HL, et al. The number of years lived with obesity and the risk of all-cause and cause-specific mortality. Int J Epidemiol. 2011;40: 985-96. [PMID: 21357186] doi:10.1093/ije/dyr018
32. Abdullah A, Stoelwinder J, Shortreed S, Wolfe R, Stevenson C, Walls H, et al. The duration of obesity and the risk of type 2 diabetes. Public Health Nutr. 2011;14:119-26. [PMID: 20587115] doi:10.1017/S1368980010001813
33. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85:2402-10. [PMID: 10902785]